Skip to main content
. 2023 Aug 14;61(1):42–54. doi: 10.1007/s12035-023-03523-4

Table 2.

Allele frequencies and genotype distributions in patients with ADHD and in normal controls, segmented by gender

Gene SNP Model Genotype Total Male Female
Control/Case OR (95%CI) P Control/Case OR (95%CI) P Control/Case OR (95%CI) P
DRD2 rs1124491 Codominant G/G 79/69 1 0.27 49/49 1 0.89 30/20 1 0.098
A/G 48/60 1.43(0.87–2.36) 36/41 1.14 (0.63–2.07) 12/19 2.37 (0.95–5.95)
A/A 5/8 1.83(0.57–5.86) 4/5 1.25 (0.32–4.93) 1/3 4.50(0.44–46.38)
Dominant G/G 79/69 1 0.12 49/49 1 0.64 30/20 1 0.037
A/G-A/A 53/68 1.47(0.91–2.38) 40/46 1.15 (0.64–2.05) 13/22 2.54 (1.04–6.18)
Recessive G/G-A/G 127/129 1 0.43 85/90 1 0.81 42/39 1 0.28
A/A 5/8 1.58(0.50–4.94) 4/5 1.18 (0.31–4.54) 1/3 3.23(0.32–32.38)
Overdominat G/G-A/A 84/77 1 0.21 53/54 1 0.71 31/23 1 0.096
A/G 48/60 1.36(0.84–2.22) 36/41 1.12 (0.62–2.01) 12/19 2.13 (0.87–5.26)
rs6277 Codominant G/G 87/71 1 0.025* 70/52 1 0.0017* 17/19 1 0.74
G/A 40/64 1.96 (1.18–3.25) 17/41 3.25 (1.66–6.34) 23/23 0.89 (0.37–2.14)
A/A 6/9 1.84 (0.62–5.14) 4/5 1.68 (0.43–6.58) 2/4 1.79(0.29–11.04)
Dominant G/G 87/71 1 0.006* 70/52 1 0.00005* 17/19 1 0.94
G/A-A/A 46/73 1.94 (1.20–3.16) 21/46 2.95 (1.57–5.53) 25/27 0.97 (0.41–2.26)
Recessive G/G-G/A 127/135 1 0.52 87/93 1 0.82 40/42 1 0.46
A/A 6/9 1.41 (0.49–4.08) 4/5 1.17 (0.30–4.50) 2/4 1.90(0.33–10.98)
Overdominat G/G-A/A 93/80 1 0.013* 74/57 1 0.00005* 19/23 1 0.66
G/A 40/64 1.86 (1.13–3.05) 17/41 3.13 (1.61–6.07) 23/23 0.83 (0.36–1.91)
rs1079727 Codominant T/T 76/70 1 0.39 48/47 1 0.88 28/23 1 0.24
C/T 49/53 1.17 (0.71–1.95) 36/37 1.05 (0.57–1.93) 13/16 1.50 (0.60–3.75)
C/C 9/15 1.81 (0.74–4.40) 7/9 1.31 (0.45–3.81) 2/6 3.65(0.67–19.85)
Dominant T/T 76/70 1 0.32 48/47 1 0.76 28/23 1 0.18
C/T-C/C 58/68 1.27 (0.79–2.05) 43/46 1.09 (0.61–1.95) 15/22 1.79 (0.76–4.21)
Recessive T/T-C/T 125/123 1 0.22 84/84 1 0.63 41/39 1 0.15
C/C 9/15 1.69 (0.71–4.02) 7/9 1.29 (0.46–3.61) 2/6 3.15(0.60–16.58)
Overdominat T/T-C/C 85/85 1 0.75 55/56 1 0.98 30/29 1 0.6
C/T 49/53 1.08 (0.66–1.77) 36/37 1.01 (0.56–1.82) 13/16 1.27 (0.52–3.11)
rs6278 Codominant C/C 75/75 1 0.83 47/53 1 0.76 28/22 1 0.11
C/A 53/60 1.13 (0.69–1.85) 40/42 0.93 (0.52–1.67) 13/18 1.76 (0.71–4.36)
A/A 8/10 1.25 (0.47–3.34) 7/5 0.63 (0.19–2.13) 1/5 6.36(0.69–58.50)
Dominant C/C 75/75 1 0.57 47/53 1 0.68 28/22 1 0.092
C/A-A/A 61/70 1.15 (0.72–1.83) 47/47 0.89 (0.50–1.56) 14/23 2.09 (0.88–4.98)
Recessive C/C-C/A 128/135 1 0.73 87/95 1 0.48 41/40 1 0.093
A/A 8/10 1.19 (0.45–3.10) 7/5 0.65 (0.20–2.14) 1/5 5.12(0.57–45.83)
Overdominat C/C-A/A 83/85 1 0.68 54/58 1 0.94 29/27 1 0.38
C/A 53/60 1.11 (0.69–1.78) 40/42 0.98 (0.55–1.73) 13/18 1.49 (0.61–3.60)
rs6275 Codominant G/G 45/22 1 0.0013* 30/12 1 0.0036* 15/10 1 0.14
A/G 72/86 2.44 (1.34–4.44) 52/67 3.22 (1.50–6.90) 20/19 1.43 (0.52–3.94)
A/A 20/35 3.58 (1.69–7.57) 13/20 3.85 (1.46–10.12) 7/15 3.21 (0.97–10.69)
Dominant G/G 45/22 1 0.00006* 30/12 1 0.00009* 15/10 1 0.18
A/G-A/A 92/121 2.69 (1.51–4.79) 65/87 3.35 (1.59–7.03) 27/34 1.89 (0.73–4.87)
Recessive G/G-A/G 117/108 1 0.036* 82/79 1 0.23 35/29 1 0.062
A/A 20/35 1.90 (1.03–3.48) 13/20 1.60 (0.74–3.43) 7/15 2.59 (0.93-–7.20)
Overdominat G/G-A/A 65/57 1 0.20 43/32 1 0.064 22/25 1 0.68
A/G 72/86 1.36 (0.85–2.19) 52/67 1.73 (0.97–3.10) 20/19 0.84 (0.36–1.96)
SLC6A3 rs2652511 Codominant A/A 70/97 1 0.013* 51/66 1 0.078 19/30 1 0.011*
A/G 54/39 0.52 (0.31–0.87) 38/24 0.49 (0.26–0.91) 16/15 0.57 (0.23–1.42)
G/G 16/9 0.41 (0.17–0.97) 8/8 0.77 (0.27–2.20) 8/1 0.08 (0.01–0.80)
Dominant A/A 70/97 1 0.0037* 51/66 1 0.035 19/31 1 0.037*
A/G-G/G 70/48 0.49 (0.31–0.80) 46/32 0.54 (0.30–0.96) 24/16 0.41 (0.17–0.96)
Recessive A/A-A/G 124/136 1 0.12 89/90 1 0.98 35/46 1 0.0061*
G/G 16/9 0.51 (0.22–1.20) 8/8 0.99 (0.36–2.75) 8/1 0.10 (0.01–0.80)
Overdominat A/A-G/G 86/106 1 0.035 59/74 1 0.027 27/32 1 0.6
A/G 54/39 0.59 (0.36–0.97) 38/24 0.50 (0.27–0.93) 16/15 0.79 (0.33–1.89)
rs6347 Codominant T/T 96/103 1 0.9 63/70 1 0.68 33/33 1 0.45
T/C 37/35 0.88 (0.51–1.51) 29/25 0.78 (0.41–1.46) 8/10 1.25 (0.44–3.56)
C/C 3/3 0.93 (0.18–4.73) 2/3 1.35 (0.22–8.34) 1/0 0.00 (0.00-NA)
Dominant T/T 96/103 1 0.65 63/70 1 0.51 33/33 1 0.84
T/C-C/C 40/38 0.89 (0.52–1.50) 31/28 0.81 (0.44–1.50) 9/10 1.11 (0.40–3.09)
Recessive T/T-T/C 133/138 1 0.96 92/95 1 0.68 41/43 1 0.23
C/C 3/3 0.96 (0.19–4.86) 2/3 1.45 (0.24–8.89) 1/0 0.00 (0.00-NA)
Overdominat T/T-C/C 99/106 1 0.65 65/73 1 0.41 34/33 1 0.63
T/C 37/35 0.88 (0.52–1.51) 29/25 0.77 (0.41–1.44) 8/10 1.29 (0.45–3.66)
rs2975226 Codominant A/A 41/48 1 0.72 29/29 1 0.98 12/19 1 0.33
A/T 75/71 0.81 (0.48–1.37) 50/49 0.98 (0.51–1.87) 25/22 0.56 (0.22–1.40)
T/T 22/21 0.82 (0.39–1.69) 17/18 1.06 (0.46–2.45) 5/3 0.38 (0.08–1.88)
Dominant A/A 41/48 1 0.41 29/29 1 1 12/19 1 0.16
A/T-T/T 97/92 0.81 (0.49–1.34) 67/67 1.00 (0.54–1.85) 30/25 0.53 (0.21–1.29)
Recessive A/A-A/T 116/119 1 0.83 79/78 1 0.85 37/41 1 0.42
T/T 22/21 0.93 (0.49–1.78) 17/18 1.07 (0.52–2.23) 5/3 0.54 (0.12–2.42)
Overdominat A/A-T/T 63/69 1 0.54 46/47 1 0.89 17/22 1 0.37
A/T 75/71 0.86 (0.54–1.38) 50/49 0.96 (0.54–1.69) 25/22 0.68 (0.29–1.60)
GRIN2B rs1012586 Codominant C/C 45/29 1 0.079 28/17 1 0.16 17/12 1 0.44
G/C 64/79 1.92 (1.08–3.39) 49/59 1.98 (0.97–4.04) 1520 1.89 (0.70–5.12)
G/G 25/24 1.49 (0.72–3.09) 16/16 1.65 (0.66–4.13) 9/8 1.26 (0.38–4.20)
Dominant C/C 45/29 1 0.034 28/17 1 0.064 17/12 1 0.28
G/C-G/G 89/103 1.80 (1.04–3.10) 65/75 1.90 (0.96–3.78) 24/28 1.65 (0.66–4.14)
Recessive C/C-G/C 109/108 1 0.92 77/76 1 0.97 32/32 1 0.83
G/G 25/24 0.97 (0.52–1.80) 16/16 1.01 (0.47–2.17) 9/8 0.89 (0.30–2.59)
Overdominat C/C-G/G 70/53 1 0.048 44/33 1 0.11 26/20 1 0.09
G/C 64/79 1.63 (1.00–2.65) 49/59 1.61 (0.89–2.89) 15/20 1.73 (0.71–4.21)
rs2268119 Codominant A/A 46/52 1 0.69 36/37 1 0.68 10/15 1 0.068
A/T 69/69 0.88 (0.53–1.49) 47/44 0.91 (0.49–1.69) 22/25 0.76 (0.28–2.03)
T/T 22/18 0.72 (0.35–1.51) 10/14 1.36 (0.54–3.46) 12/4 0.22 (0.06–0.89)
Dominant A/A 46/52 1 0.51 36/37 1 0.97 10/15 1 0.24
A/T-T/T 91/87 0.85 (0.52–1.39) 57/58 0.99 (0.55–1.78) 34/29 0.57 (0.22–1.46)
Recessive A/A-A/T 115/121 1 0.46 83/81 1 0.41 32/40 1 0.024
T/T 22/18 0.78 (0.40–1.52) 10/14 1.43 (0.60–3.41) 12/4 0.27 (0.08–0.91)
Overdominat A/A-T/T 68/70 1 0.9 46/51 1 0.56 22/19 1 0.52
A/T 69/69 0.97 (0.61–1.56) 47/44 0.84 (0.48–1.50) 22/25 1.32 (0.57–3.05)
rs1805502 Codominant A/A 85/83 1 0.37 59/59 1 0.32 26/24 1 0.72
G/A 36/49 1.39 (0.82–2.36) 23/32 1.39 (0.73–2.65) 13/17 1.42 (0.57–3.52)
G/G 9/7 0.80 (0.28–2.24) 6/3 0.50 (0.12–2.09) 3/4 1.44 (0.29–7.13)
Dominant A/A 85/83 1 0.34 59/59 1 0.55 26/24 1 0.42
G/A-G/G 45/56 1.27 (0.78–2.09) 29/35 1.21 (0.66–2.22) 16/21 1.42 (0.60–3.34)
Recessive A/A-G/A 121/132 1 0.51 82/91 1 0.26 39/41 1 0.76
G/G 9/7 0.71 (0.26–1.97) 6/3 0.45 (0.11–1.86) 3/4 1.27 (0.27–6.03)
Overdominat A/A-G/G 94/90 1 0.18 65/62 1 0.24 29/28 1 0.5
G/A 36/49 1.42 (0.85–2.39) 23/32 1.46 (0.77–2.76) 13/17 1.35 (0.56–3.30)
rs7301328 Codominant G/G 39/35 1 0.86 28/23 1 0.71 11/12 1 0.87
C/G 72/73 1.13 (0.64–1.98) 48/52 1.32 (0.67–2.60) 24/21 0.80 (0.29–2.19)
C/C 27/29 1.20 (0.60–2.40) 18/19 1.29 (0.55–3.00) 9/10 1.02 (0.30–3.44)
Dominant G/G 39/35 1 0.61 28/23 1 0.41 11/12 1 0.76
C/G-C/C 99/102 1.15 (0.67–1.96) 66/71 1.31 (0.69–2.50) 33/31 0.86 (0.33–2.24)
Recessive G/G-C/G 111/108 1 0.74 76/75 1 0.85 35/33 1 0.75
C/C 27/29 1.10 (0.61–1.99) 18/19 1.07 (0.52–2.20) 9/10 1.18 (0.43–3.26)
Overdominat G/G-C/C 66/64 1 0.85 46/42 1 0.56 20/22 1 0.59
C/G 72/73 1.05 (0.65–1.68) 48/52 1.19 (0.67–2.11) 24/21 0.80 (0.34–1.85)
rs1806191 Codominant G/G 98/88 1 0.44 71/62 1 0.32 27/26 1 1
A/G 37/44 1.32 (0.78–2.24) 22/29 1.51 (0.79–2.89) 15/15 1.04 (0.42–2.54)
A/A 3/5 1.86 (0.43–7.99) 2/4 2.29 (0.41–12.94) 1/1 1.04(0.06–17.49)
Dominant G/G 98/88 1 0.23 71/62 1 0.15 27/26 1 0.93
A/G-A/A 40/49 1.36 (0.82–2.27) 24/33 1.57 (0.84–2.95) 16/16 1.04 (0.43–2.50)
Recessive G/G-A/G 135/132 1 0.46 93/91 1 0.4 42/41 1 0.99
A/A 3/5 1.70 (0.40–7.27) 2/4 2.04 (0.37–11.44) 1/1 1.02(0.06–16.93)
Overdominat G/G-A/A 101/93 1 0.33 73/66 1 0.25 28/27 1 0.94
A/G 37/44 1.29 (0.77–2.17) 22/29 1.46 (0.76–2.78) 15/15 1.04 (0.43–2.52)

a* Indicates that p-value is statistically significant after FDR correction